Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%
ERICKSON AIR EAC
5.10%
ASSURED GUAR AGO
4.98%

Celanese to Build Methanol Plant

by Zacks Equity Research

June 15, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

The specialty material company, Celanese Corporation (CE - Analyst Report) announced its plan to build a methanol plant at its Clear Lake, Texas acetyl complex with an annual capacity of 1.3 million metric ton. The plant is expected to be online by July 1, 2015.

A considerable portion of the methanol produced at the plant will be used to support Celanese’s acetyl operations at Clear Lake. The company expects to partner with one or more additional entities to sell the remaining methanol, provided they are interested in it.

The company aims to utilize its already existing infrastructure at Clear Lake for the new plant, which will help reduce its capital requirements. Celanese also intends to take advantage of the existing technologies at the facility. The facility will provide employment to a large number of people through the construction process as well as the start up phase.

In April 2012, Celanese released its first-quarter 2012 results. The company reported adjusted earnings (excluding one-time charges and gains) of 72 cents per share in the quarter, down from 96 cents a year ago. The profits were below the Zacks Consensus Estimate of 77 cents. However, the reported profit jumped 28.9% year over year to $183 million or $1.15 per share during the quarter.

Sales for the quarter amounted to $1,633 million, up 3% year over year, exceeding the Zacks Consensus Estimate of $1,616 million. The growth was driven by higher volumes and pricing in the company’s acetyl intermediates and industrial specialties divisions. However, higher costs and weaker demand in Europe led to a decline in operating profit by 91.8% to $98 million.

According to Celanese, challenging market conditions in Europe and Asia will last longer this year than expected. Therefore, the company will operate plants at appropriate levels to maximize profits while keeping a lid on discretionary spending. It expects to cut costs and expand customer relationships to counteract weak demand.

Celanese, which competes with BASF SE (BASFY) and Methanex Corporation (MEOH - Analyst Report), currently retains a Zacks #3 Rank, reflecting a short-term (1 to 3 months) Hold rating. Currently, we have a long-term (more than 6 months) Neutral recommendation on the stock.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.